Previous 10 |
Kazia Licenses Rights to Paxalisib in Greater China to Simcere, a Leading Chinese Pharmaceutical Company PR Newswire SYDNEY , March 29, 2021 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an oncology-focused drug development company, is ple...
Kazia Licenses Cantrixil, a Clinical-stage, First-in-class Ovarian Cancer Drug Candidate, to Oasmia Pharmacetical AB PR Newswire SYDNEY , March 1, 2021 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnolo...
Kazia Therapeutics (KZIA) has granted worldwide exclusive rights to develop and commercialize Cantrixil (TRX-E-002-1) to Oasmia Pharmaceutical AB (OASMY) targeting all indications, with an initial focus on ovarian cancer.Under the terms of the agreement, the Swedish biotech firm wil...
Gainers: Triumph Group (NYSE: TGI ) +27% . ToughBuilt Industries (NASDAQ: TBLT ) +25% . Kazia Therapeutics (NASDAQ: KZIA ) +26% . vTv Therapeutics (NASDAQ: VTVT ) +18% . Xilinx (NASDAQ: XLNX ) +18% . Resonant (NASDAQ: RESN ) +13% . ASLAN Pharmaceuticals (NASDAQ: ASLN ) +16% . ...
SYDNEY , Nov. 20, 2018 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that the Share Purchase Plan (SPP), as described in the SPP booklet dated 23 October 2018 , has now been successfully c...
SYDNEY , Oct. 29, 2018 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to provide an update to shareholders regarding progress with GDC-0084, which is currently in human trials for glioblastoma and sever...
News, Short Squeeze, Breakout and More Instantly...
Kazia Therapeutics Limited Company Name:
KZIA Stock Symbol:
NASDAQ Market:
Kazia Therapeutics Limited Website:
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 0.6% to $128.44 on volume of 203,267,889 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 22.1% to $0.5152 on volume of 200,531,827 shares PROSHARES TRUST (SQQQ) fell 0.7% to $7.46 on volume o...
A look at the top 10 most actives in the United States Qualigen Therapeutics Inc. (QLGN) rose 111.4% to $0.4341 on volume of 412,713,755 shares Maxeon Solar Technologies Ltd. (MAXN) fell 1.3% to $0.2375 on volume of 280,800,277 shares NVIDIA Corporation (NVDA) rose 1.4% to $129.24 on volu...